BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 744640 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H23Cl2FN4O4/c31-16-7-9-19-22(11-16)34-29(40)30(19)24(18-2-1-3-20(32)25(18)33)26-23(36(30)12-14-4-5-14)13-41-27-17-8-6-15(28(38)39)10-21(17)35-37(26)27/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m0/s1 YZMITHOPDOPJBH-HLNVOFQHSA-N 374730 US10246467, Example I-1::US10246467, Example I-2::US10919913, # I-2 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 9.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374730&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376431 404343790 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744641 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H23Cl2FN4O4/c31-16-7-9-19-22(11-16)34-29(40)30(19)24(18-2-1-3-20(32)25(18)33)26-23(36(30)12-14-4-5-14)13-41-27-17-8-6-15(28(38)39)10-21(17)35-37(26)27/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m0/s1 YZMITHOPDOPJBH-HLNVOFQHSA-N 374730 US10246467, Example I-1::US10246467, Example I-2::US10919913, # I-2 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 5.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374730&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376431 404343790 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744642 OC(=O)c1ccc2c3OC[C@@H]4[C@@H]([C@@H](c5cccc(Cl)c5F)[C@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H23Cl2FN4O4/c31-16-7-9-19-22(11-16)34-29(40)30(19)24(18-2-1-3-20(32)25(18)33)26-23(36(30)12-14-4-5-14)13-41-27-17-8-6-15(28(38)39)10-21(17)35-37(26)27/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m1/s1 YZMITHOPDOPJBH-NFDQLLMUSA-N 374732 US10246467, Example I-3::US10919913, # I-3 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 557 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374732&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376432 404343791 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744643 OC(=O)c1ccc2nn3[C@@H]4[C@H](COc3c2c1)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H23Cl2FN4O4/c31-16-7-8-19-22(11-16)34-29(40)30(19)24(17-2-1-3-20(32)25(17)33)26-23(36(30)12-14-4-5-14)13-41-27-18-10-15(28(38)39)6-9-21(18)35-37(26)27/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m0/s1 JJCQXIRROLOGAC-HLNVOFQHSA-N 374733 US10246467, Example I-4::US10246467, Example I-5::US10919913, # I-5 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 8.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374733&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376433 404343792 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744644 OC(=O)c1ccc2nn3[C@@H]4[C@H](COc3c2c1)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H23Cl2FN4O4/c31-16-7-8-19-22(11-16)34-29(40)30(19)24(17-2-1-3-20(32)25(17)33)26-23(36(30)12-14-4-5-14)13-41-27-18-10-15(28(38)39)6-9-21(18)35-37(26)27/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m0/s1 JJCQXIRROLOGAC-HLNVOFQHSA-N 374733 US10246467, Example I-4::US10246467, Example I-5::US10919913, # I-5 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 7.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374733&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376433 404343792 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744645 OC(=O)c1ccc2nn3[C@H]4[C@@H](COc3c2c1)N(CC1CC1)[C@@]1([C@@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H23Cl2FN4O4/c31-16-7-8-19-22(11-16)34-29(40)30(19)24(17-2-1-3-20(32)25(17)33)26-23(36(30)12-14-4-5-14)13-41-27-18-10-15(28(38)39)6-9-21(18)35-37(26)27/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m1/s1 JJCQXIRROLOGAC-NFDQLLMUSA-N 374735 US10246467, Example I-6::US10919913, # I-6 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 619 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374735&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376434 404343793 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744646 COc1cc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2cc1C(O)=O InChI=1S/C31H25Cl2FN4O5/c1-42-24-11-17-21(10-18(24)29(39)40)36-38-27-23(13-43-28(17)38)37(12-14-5-6-14)31(25(27)16-3-2-4-20(33)26(16)34)19-8-7-15(32)9-22(19)35-30(31)41/h2-4,7-11,14,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m0/s1 XUVCZAVRKYNTAO-RXRCSWILSA-N 374736 US10246467, Example I-7::US10246467, Example I-8::US10919913, # I-8 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 9.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374736&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376344 404343794 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744647 COc1cc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2cc1C(O)=O InChI=1S/C31H25Cl2FN4O5/c1-42-24-11-17-21(10-18(24)29(39)40)36-38-27-23(13-43-28(17)38)37(12-14-5-6-14)31(25(27)16-3-2-4-20(33)26(16)34)19-8-7-15(32)9-22(19)35-30(31)41/h2-4,7-11,14,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m0/s1 XUVCZAVRKYNTAO-RXRCSWILSA-N 374736 US10246467, Example I-7::US10246467, Example I-8::US10919913, # I-8 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 5.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374736&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376344 404343794 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744648 COc1cc2c3OC[C@@H]4[C@@H]([C@@H](c5cccc(Cl)c5F)[C@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2cc1C(O)=O InChI=1S/C31H25Cl2FN4O5/c1-42-24-11-17-21(10-18(24)29(39)40)36-38-27-23(13-43-28(17)38)37(12-14-5-6-14)31(25(27)16-3-2-4-20(33)26(16)34)19-8-7-15(32)9-22(19)35-30(31)41/h2-4,7-11,14,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m1/s1 XUVCZAVRKYNTAO-OVRLWXHPSA-N 374738 US10246467, Example I-9::US10919913, # I-9 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 818 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374738&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 118895882 404343795 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744649 COc1cc2nn3[C@@H]4[C@H](COc3c2cc1C(O)=O)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O5/c1-42-24-11-21-17(10-18(24)29(39)40)28-38(36-21)27-23(13-43-28)37(12-14-5-6-14)31(25(27)16-3-2-4-20(33)26(16)34)19-8-7-15(32)9-22(19)35-30(31)41/h2-4,7-11,14,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m0/s1 JURMESUCSRKLSS-RXRCSWILSA-N 374739 US10246467, Example I-10::US10246467, Example I-11::US10919913, # I-11 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 18.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374739&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376435 404343796 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744650 COc1cc2nn3[C@@H]4[C@H](COc3c2cc1C(O)=O)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O5/c1-42-24-11-21-17(10-18(24)29(39)40)28-38(36-21)27-23(13-43-28)37(12-14-5-6-14)31(25(27)16-3-2-4-20(33)26(16)34)19-8-7-15(32)9-22(19)35-30(31)41/h2-4,7-11,14,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m0/s1 JURMESUCSRKLSS-RXRCSWILSA-N 374739 US10246467, Example I-10::US10246467, Example I-11::US10919913, # I-11 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 10.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374739&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376435 404343796 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744651 COc1cc2nn3[C@H]4[C@@H](COc3c2cc1C(O)=O)N(CC1CC1)[C@@]1([C@@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O5/c1-42-24-11-21-17(10-18(24)29(39)40)28-38(36-21)27-23(13-43-28)37(12-14-5-6-14)31(25(27)16-3-2-4-20(33)26(16)34)19-8-7-15(32)9-22(19)35-30(31)41/h2-4,7-11,14,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m1/s1 JURMESUCSRKLSS-OVRLWXHPSA-N 374741 US10246467, Example I-12::US10919913, # I-12 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 986 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374741&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376436 404343797 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744652 CS(=O)(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H25Cl2FN4O4S/c1-42(39,40)17-8-9-18-22(12-17)35-37-27-24(14-41-28(18)37)36(13-15-5-6-15)30(25(27)19-3-2-4-21(32)26(19)33)20-10-7-16(31)11-23(20)34-29(30)38/h2-4,7-12,15,24-25,27H,5-6,13-14H2,1H3,(H,34,38)/t24-,25-,27+,30+/m0/s1 VDSFSAYTPKMMRH-VBVRERCOSA-N 374742 US10246467, Example I-13::US10246467, Example I-14::US10919913, # I-14 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 87.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374742&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376437 404343798 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744653 CS(=O)(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H25Cl2FN4O4S/c1-42(39,40)17-8-9-18-22(12-17)35-37-27-24(14-41-28(18)37)36(13-15-5-6-15)30(25(27)19-3-2-4-21(32)26(19)33)20-10-7-16(31)11-23(20)34-29(30)38/h2-4,7-12,15,24-25,27H,5-6,13-14H2,1H3,(H,34,38)/t24-,25-,27+,30+/m0/s1 VDSFSAYTPKMMRH-VBVRERCOSA-N 374742 US10246467, Example I-13::US10246467, Example I-14::US10919913, # I-14 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 51.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374742&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376437 404343798 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744654 CS(=O)(=O)c1ccc2c3OC[C@@H]4[C@@H]([C@@H](c5cccc(Cl)c5F)[C@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H25Cl2FN4O4S/c1-42(39,40)17-8-9-18-22(12-17)35-37-27-24(14-41-28(18)37)36(13-15-5-6-15)30(25(27)19-3-2-4-21(32)26(19)33)20-10-7-16(31)11-23(20)34-29(30)38/h2-4,7-12,15,24-25,27H,5-6,13-14H2,1H3,(H,34,38)/t24-,25-,27+,30+/m1/s1 VDSFSAYTPKMMRH-RRRLRPSDSA-N 374744 US10246467, Example I-15::US10919913, # I-15 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 261 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374744&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376438 404343799 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744655 COc1cc2nn3[C@@H]4[C@H](COc3c2cc1C#N)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H24Cl2FN5O3/c1-41-25-11-22-19(9-16(25)12-35)29-39(37-22)28-24(14-42-29)38(13-15-5-6-15)31(26(28)18-3-2-4-21(33)27(18)34)20-8-7-17(32)10-23(20)36-30(31)40/h2-4,7-11,15,24,26,28H,5-6,13-14H2,1H3,(H,36,40)/t24-,26-,28+,31+/m0/s1 DBQQVGHPOOQHRX-XYKPQQNDSA-N 374745 US10246467, Example I-16::US10919913, # I-16 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 331 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374745&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376440 404343800 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744656 C[C@H]1Oc2n(nc3cc(ccc23)C(O)=O)[C@@H]2[C@H]1N(CC1CC1)[C@]1([C@H]2c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c1-14-26-27(38-28(42-14)18-9-7-16(29(39)40)11-22(18)36-38)24(19-3-2-4-21(33)25(19)34)31(37(26)13-15-5-6-15)20-10-8-17(32)12-23(20)35-30(31)41/h2-4,7-12,14-15,24,26-27H,5-6,13H2,1H3,(H,35,41)(H,39,40)/t14-,24+,26+,27+,31-/m1/s1 SDVAEDVASKNSQX-CPMVGPJYSA-N 374746 US10246467, Example I-28::US10919913, # I-28 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 51.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374746&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376445 404343801 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744657 C[C@H]1Oc2n(nc3cc(ccc23)C(O)=O)[C@H]2[C@@H]1N(CC1CC1)[C@@]1([C@@H]2c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c1-14-26-27(38-28(42-14)18-9-7-16(29(39)40)11-22(18)36-38)24(19-3-2-4-21(33)25(19)34)31(37(26)13-15-5-6-15)20-10-8-17(32)12-23(20)35-30(31)41/h2-4,7-12,14-15,24,26-27H,5-6,13H2,1H3,(H,35,41)(H,39,40)/t14-,24-,26-,27-,31+/m1/s1 SDVAEDVASKNSQX-IREGEPEUSA-N 374747 US10246467, Example I-29::US10919913, # I-29 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 520 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374747&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376446 404343802 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744658 C[C@@H]1Oc2n(nc3cc(ccc23)C(O)=O)[C@@H]2[C@H]1N(CC1CC1)[C@]1([C@H]2c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c1-14-26-27(38-28(42-14)18-9-7-16(29(39)40)11-22(18)36-38)24(19-3-2-4-21(33)25(19)34)31(37(26)13-15-5-6-15)20-10-8-17(32)12-23(20)35-30(31)41/h2-4,7-12,14-15,24,26-27H,5-6,13H2,1H3,(H,35,41)(H,39,40)/t14-,24-,26-,27-,31+/m0/s1 SDVAEDVASKNSQX-ATUJTIGVSA-N 374748 US10246467, Example I-30::US10919913, # I-30 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 10.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374748&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376447 404343803 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744659 C[C@@H]1Oc2n(nc3cc(ccc23)C(O)=O)[C@H]2[C@@H]1N(CC1CC1)[C@@]1([C@@H]2c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c1-14-26-27(38-28(42-14)18-9-7-16(29(39)40)11-22(18)36-38)24(19-3-2-4-21(33)25(19)34)31(37(26)13-15-5-6-15)20-10-8-17(32)12-23(20)35-30(31)41/h2-4,7-12,14-15,24,26-27H,5-6,13H2,1H3,(H,35,41)(H,39,40)/t14-,24+,26+,27+,31-/m0/s1 SDVAEDVASKNSQX-LTUPPYKUSA-N 374749 US10246467, Example I-31::US10919913, # I-31 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 100.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374749&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376449 404343804 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744660 CC(C)(C)CN1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H27Cl2FN4O4/c1-30(2,3)14-37-23-13-42-27-17-9-7-15(28(39)40)11-21(17)36-38(27)26(23)24(18-5-4-6-20(33)25(18)34)31(37)19-10-8-16(32)12-22(19)35-29(31)41/h4-12,23-24,26H,13-14H2,1-3H3,(H,35,41)(H,39,40)/t23-,24-,26+,31+/m0/s1 XDVHTKVLJNJURH-ISKXDESKSA-N 374750 US10246467, Example I-32::US10246467, Example I-33::US10919913, # I-33 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 19.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374750&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376448 404343805 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744661 CC(C)(C)CN1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H27Cl2FN4O4/c1-30(2,3)14-37-23-13-42-27-17-9-7-15(28(39)40)11-21(17)36-38(27)26(23)24(18-5-4-6-20(33)25(18)34)31(37)19-10-8-16(32)12-22(19)35-29(31)41/h4-12,23-24,26H,13-14H2,1-3H3,(H,35,41)(H,39,40)/t23-,24-,26+,31+/m0/s1 XDVHTKVLJNJURH-ISKXDESKSA-N 374750 US10246467, Example I-32::US10246467, Example I-33::US10919913, # I-33 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 9.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374750&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376448 404343805 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744662 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CCC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C31H25Cl2FN4O4/c32-17-7-9-20-23(13-17)35-30(41)31(20)25(19-2-1-3-21(33)26(19)34)27-24(37(31)11-10-15-4-5-15)14-42-28-18-8-6-16(29(39)40)12-22(18)36-38(27)28/h1-3,6-9,12-13,15,24-25,27H,4-5,10-11,14H2,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 MHHRAGZRYUZXQG-NCRFVDKVSA-N 374752 US10246467, Example I-34::US10919913, # I-34 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 80.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374752&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376450 404343806 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744663 CC(C)CN1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H25Cl2FN4O4/c1-14(2)12-36-23-13-41-27-17-8-6-15(28(38)39)10-21(17)35-37(27)26(23)24(18-4-3-5-20(32)25(18)33)30(36)19-9-7-16(31)11-22(19)34-29(30)40/h3-11,14,23-24,26H,12-13H2,1-2H3,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m0/s1 BFYPYKNJQADWEI-HLNVOFQHSA-N 374753 US10246467, Example I-36::US10246467, Example I-37::US10919913, # I-37 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 16.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374753&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376451 404343807 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744664 CC(C)CN1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H25Cl2FN4O4/c1-14(2)12-36-23-13-41-27-17-8-6-15(28(38)39)10-21(17)35-37(27)26(23)24(18-4-3-5-20(32)25(18)33)30(36)19-9-7-16(31)11-22(19)34-29(30)40/h3-11,14,23-24,26H,12-13H2,1-2H3,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m0/s1 BFYPYKNJQADWEI-HLNVOFQHSA-N 374753 US10246467, Example I-36::US10246467, Example I-37::US10919913, # I-37 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 12.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374753&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376451 404343807 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744665 CC(C)CN1[C@@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@@H]2[C@@H](c2cccc(Cl)c2F)[C@@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H25Cl2FN4O4/c1-14(2)12-36-23-13-41-27-17-8-6-15(28(38)39)10-21(17)35-37(27)26(23)24(18-4-3-5-20(32)25(18)33)30(36)19-9-7-16(31)11-22(19)34-29(30)40/h3-11,14,23-24,26H,12-13H2,1-2H3,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m1/s1 BFYPYKNJQADWEI-NFDQLLMUSA-N 374755 US10246467, Example I-38::US10919913, # I-38 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 797 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374755&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376452 404343808 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744666 CC(C)CCN1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H27Cl2FN4O4/c1-15(2)10-11-37-24-14-42-28-18-8-6-16(29(39)40)12-22(18)36-38(28)27(24)25(19-4-3-5-21(33)26(19)34)31(37)20-9-7-17(32)13-23(20)35-30(31)41/h3-9,12-13,15,24-25,27H,10-11,14H2,1-2H3,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 RQPNXVDALDRZEU-NCRFVDKVSA-N 374756 US10246467, Example I-39::US10919913, # I-39 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 48.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374756&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376453 404343809 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744667 CC(C)=CCN1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c1-15(2)10-11-37-24-14-42-28-18-8-6-16(29(39)40)12-22(18)36-38(28)27(24)25(19-4-3-5-21(33)26(19)34)31(37)20-9-7-17(32)13-23(20)35-30(31)41/h3-10,12-13,24-25,27H,11,14H2,1-2H3,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 QFJKZQDZTQLAPD-NCRFVDKVSA-N 374757 US10246467, Example I-41::US10919913, # I-41 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 40.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374757&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376454 404343810 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744668 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CCC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C31H25Cl2FN4O4/c32-17-8-10-20-23(12-17)35-30(41)31(20)25(19-5-2-6-21(33)26(19)34)27-24(37(31)13-15-3-1-4-15)14-42-28-18-9-7-16(29(39)40)11-22(18)36-38(27)28/h2,5-12,15,24-25,27H,1,3-4,13-14H2,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 QTSMRTNOGFBVTO-NCRFVDKVSA-N 374758 US10246467, Example I-43::US10919913, # I-43 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 20.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374758&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376455 404343811 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744669 CC1CC1CN1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c1-14-9-16(14)12-37-24-13-42-28-18-7-5-15(29(39)40)10-22(18)36-38(28)27(24)25(19-3-2-4-21(33)26(19)34)31(37)20-8-6-17(32)11-23(20)35-30(31)41/h2-8,10-11,14,16,24-25,27H,9,12-13H2,1H3,(H,35,41)(H,39,40)/t14?,16?,24-,25-,27+,31+/m0/s1 IIMKYIXMERGUPL-MPLCTNQTSA-N 374759 US10246467, Example I-45::US10919913, # I-45 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 97.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374759&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376456 404343812 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744670 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4(F)F)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H21Cl2F3N4O4/c31-15-5-7-18-21(9-15)36-28(42)30(18)23(17-2-1-3-19(32)24(17)33)25-22(38(30)11-14-10-29(14,34)35)12-43-26-16-6-4-13(27(40)41)8-20(16)37-39(25)26/h1-9,14,22-23,25H,10-12H2,(H,36,42)(H,40,41)/t14?,22-,23-,25+,30+/m0/s1 RLUCXXWXLKLQLP-UPKXIKCVSA-N 374760 US10246467, Example I-47::US10919913, # I-47 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 19.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374760&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376457 404343813 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744671 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CCCC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C32H27Cl2FN4O4/c33-18-9-11-21-24(13-18)36-31(42)32(21)26(20-6-3-7-22(34)27(20)35)28-25(38(32)14-16-4-1-2-5-16)15-43-29-19-10-8-17(30(40)41)12-23(19)37-39(28)29/h3,6-13,16,25-26,28H,1-2,4-5,14-15H2,(H,36,42)(H,40,41)/t25-,26-,28+,32+/m0/s1 BUHMVSNQRFYGLY-CKHSQSCFSA-N 374761 US10246467, Example I-49::US10919913, # I-49 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 37.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374761&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376458 404343814 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744672 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CCOC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C31H25Cl2FN4O5/c32-17-5-7-20-23(11-17)35-30(41)31(20)25(19-2-1-3-21(33)26(19)34)27-24(37(31)12-15-8-9-42-13-15)14-43-28-18-6-4-16(29(39)40)10-22(18)36-38(27)28/h1-7,10-11,15,24-25,27H,8-9,12-14H2,(H,35,41)(H,39,40)/t15?,24-,25-,27+,31+/m0/s1 YIWFNWHPCSUTPI-BATIDXRXSA-N 374762 US10246467, Example I-51::US10919913, # I-51 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 41.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374762&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376461 404343815 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744673 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CCCCC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C33H29Cl2FN4O4/c34-19-10-12-22-25(14-19)37-32(43)33(22)27(21-7-4-8-23(35)28(21)36)29-26(39(33)15-17-5-2-1-3-6-17)16-44-30-20-11-9-18(31(41)42)13-24(20)38-40(29)30/h4,7-14,17,26-27,29H,1-3,5-6,15-16H2,(H,37,43)(H,41,42)/t26-,27-,29+,33+/m0/s1 MNVZMEAGKBVOJJ-LMFMZMNVSA-N 374763 US10246467, Example I-53::US10919913, # I-53 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 49.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374763&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376459 404343816 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744674 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4C4CCCC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C31H25Cl2FN4O4/c32-16-9-11-20-23(13-16)35-30(41)31(20)25(19-6-3-7-21(33)26(19)34)27-24(37(31)17-4-1-2-5-17)14-42-28-18-10-8-15(29(39)40)12-22(18)36-38(27)28/h3,6-13,17,24-25,27H,1-2,4-5,14H2,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 UNARVQRBYFEWAI-NCRFVDKVSA-N 374764 US10246467, Example I-55::US10919913, # I-55 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 32.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374764&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376460 404343817 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744675 C[C@H]1CC(C[C@@H]1C)N1[C@H]2COc3n(nc4cc(ccc34)C(O)=O)[C@H]2[C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12 InChI=1S/C33H29Cl2FN4O4/c1-15-10-19(11-16(15)2)39-26-14-44-30-20-8-6-17(31(41)42)12-24(20)38-40(30)29(26)27(21-4-3-5-23(35)28(21)36)33(39)22-9-7-18(34)13-25(22)37-32(33)43/h3-9,12-13,15-16,19,26-27,29H,10-11,14H2,1-2H3,(H,37,43)(H,41,42)/t15-,16-,26-,27-,29+,33+/m0/s1 KPYXMBNMDIMBLZ-LTBSGKJHSA-N 374765 US10246467, Example I-57::US10919913, # I-57 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 76.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374765&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376465 404343818 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744676 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4C4CCCCC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C32H27Cl2FN4O4/c33-17-10-12-21-24(14-17)36-31(42)32(21)26(20-7-4-8-22(34)27(20)35)28-25(38(32)18-5-2-1-3-6-18)15-43-29-19-11-9-16(30(40)41)13-23(19)37-39(28)29/h4,7-14,18,25-26,28H,1-3,5-6,15H2,(H,36,42)(H,40,41)/t25-,26-,28+,32+/m0/s1 WYGAHHDMOLTFMI-CKHSQSCFSA-N 374766 US10246467, Example I-59::US10919913, # I-59 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 36.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374766&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376463 404343819 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744677 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4C4CCCCCC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C33H29Cl2FN4O4/c34-18-11-13-22-25(15-18)37-32(43)33(22)27(21-8-5-9-23(35)28(21)36)29-26(39(33)19-6-3-1-2-4-7-19)16-44-30-20-12-10-17(31(41)42)14-24(20)38-40(29)30/h5,8-15,19,26-27,29H,1-4,6-7,16H2,(H,37,43)(H,41,42)/t26-,27-,29+,33+/m0/s1 RNOLLUXAEDHXDC-LMFMZMNVSA-N 374767 US10246467, Example I-61::US10919913, # I-61 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 32.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374767&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376462 404343820 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744678 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CCCOC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C32H27Cl2FN4O5/c33-18-7-9-21-24(12-18)36-31(42)32(21)26(20-4-1-5-22(34)27(20)35)28-25(38(32)13-16-3-2-10-43-14-16)15-44-29-19-8-6-17(30(40)41)11-23(19)37-39(28)29/h1,4-9,11-12,16,25-26,28H,2-3,10,13-15H2,(H,36,42)(H,40,41)/t16?,25-,26-,28+,32+/m0/s1 JHYFYTRJNSSZAS-LUJRYGLYSA-N 374768 US10246467, Example I-63::US10919913, # I-63 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 15.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374768&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376464 404343821 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744679 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CCOCC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C32H27Cl2FN4O5/c33-18-5-7-21-24(13-18)36-31(42)32(21)26(20-2-1-3-22(34)27(20)35)28-25(38(32)14-16-8-10-43-11-9-16)15-44-29-19-6-4-17(30(40)41)12-23(19)37-39(28)29/h1-7,12-13,16,25-26,28H,8-11,14-15H2,(H,36,42)(H,40,41)/t25-,26-,28+,32+/m0/s1 WFZLRDBQPDMPPE-CKHSQSCFSA-N 374769 US10246467, Example I-65::US10919913, # I-65 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 31.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374769&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376466 404343822 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744680 CCOc1cccc(CN2[C@H]3COc4n(nc5cc(ccc45)C(O)=O)[C@H]3[C@H](c3cccc(Cl)c3F)[C@]22C(=O)Nc3cc(Cl)ccc23)c1 InChI=1S/C35H27Cl2FN4O5/c1-2-46-21-6-3-5-18(13-21)16-41-28-17-47-32-22-11-9-19(33(43)44)14-26(22)40-42(32)31(28)29(23-7-4-8-25(37)30(23)38)35(41)24-12-10-20(36)15-27(24)39-34(35)45/h3-15,28-29,31H,2,16-17H2,1H3,(H,39,45)(H,43,44)/t28-,29-,31+,35+/m0/s1 ATDZTLRGKQSJFT-FHBKDIMNSA-N 374770 US10246467, Example I-67::US10246467, Example I-68::US10919913, # I-68 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 7.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374770&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376471 404343823 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744681 CCOc1cccc(CN2[C@H]3COc4n(nc5cc(ccc45)C(O)=O)[C@H]3[C@H](c3cccc(Cl)c3F)[C@]22C(=O)Nc3cc(Cl)ccc23)c1 InChI=1S/C35H27Cl2FN4O5/c1-2-46-21-6-3-5-18(13-21)16-41-28-17-47-32-22-11-9-19(33(43)44)14-26(22)40-42(32)31(28)29(23-7-4-8-25(37)30(23)38)35(41)24-12-10-20(36)15-27(24)39-34(35)45/h3-15,28-29,31H,2,16-17H2,1H3,(H,39,45)(H,43,44)/t28-,29-,31+,35+/m0/s1 ATDZTLRGKQSJFT-FHBKDIMNSA-N 374770 US10246467, Example I-67::US10246467, Example I-68::US10919913, # I-68 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 3.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374770&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376471 404343823 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744682 CCOc1cccc(CN2[C@@H]3COc4n(nc5cc(ccc45)C(O)=O)[C@@H]3[C@@H](c3cccc(Cl)c3F)[C@@]22C(=O)Nc3cc(Cl)ccc23)c1 InChI=1S/C35H27Cl2FN4O5/c1-2-46-21-6-3-5-18(13-21)16-41-28-17-47-32-22-11-9-19(33(43)44)14-26(22)40-42(32)31(28)29(23-7-4-8-25(37)30(23)38)35(41)24-12-10-20(36)15-27(24)39-34(35)45/h3-15,28-29,31H,2,16-17H2,1H3,(H,39,45)(H,43,44)/t28-,29-,31+,35+/m1/s1 ATDZTLRGKQSJFT-ZNJJBAKASA-N 374772 US10246467, Example I-69::US10919913, # I-69 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 2144 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374772&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376467 404343824 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744683 CCOc1cccc(CN2[C@H]3COc4n(nc5ccc(cc45)C(O)=O)[C@H]3[C@H](c3cccc(Cl)c3F)[C@]22C(=O)Nc3cc(Cl)ccc23)c1 InChI=1S/C35H27Cl2FN4O5/c1-2-46-21-6-3-5-18(13-21)16-41-28-17-47-32-23-14-19(33(43)44)9-12-26(23)40-42(32)31(28)29(22-7-4-8-25(37)30(22)38)35(41)24-11-10-20(36)15-27(24)39-34(35)45/h3-15,28-29,31H,2,16-17H2,1H3,(H,39,45)(H,43,44)/t28-,29-,31+,35+/m0/s1 QVRSVEKTVHFJFD-FHBKDIMNSA-N 374773 US10246467, Example I-70::US10919913, # I-70 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 4.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374773&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376468 404343825 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744684 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Br)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H23BrClFN4O4/c31-20-3-1-2-18(25(20)33)24-26-23(13-41-27-17-8-6-15(28(38)39)10-21(17)35-37(26)27)36(12-14-4-5-14)30(24)19-9-7-16(32)11-22(19)34-29(30)40/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H,34,40)(H,38,39)/t23-,24-,26+,30+/m0/s1 YKLDXCDBLJCTDC-HLNVOFQHSA-N 374774 US10246467, Example I-72::US10919913, # I-72 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 12.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374774&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376469 404343826 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744685 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cc(Cl)cc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H22Cl3FN4O4/c31-15-4-6-19-22(10-15)35-29(41)30(19)24(18-8-16(32)9-20(33)25(18)34)26-23(37(30)11-13-1-2-13)12-42-27-17-5-3-14(28(39)40)7-21(17)36-38(26)27/h3-10,13,23-24,26H,1-2,11-12H2,(H,35,41)(H,39,40)/t23-,24-,26+,30+/m0/s1 NXSBSZYEYXWHNG-HLNVOFQHSA-N 374775 US10246467, Example I-74::US10919913, # I-74 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 13.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374775&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376472 404343827 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744686 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5ccc(F)c(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C30H22Cl2F2N4O4/c31-15-4-7-18-21(10-15)35-29(41)30(18)23(17-6-8-19(33)24(32)25(17)34)26-22(37(30)11-13-1-2-13)12-42-27-16-5-3-14(28(39)40)9-20(16)36-38(26)27/h3-10,13,22-23,26H,1-2,11-12H2,(H,35,41)(H,39,40)/t22-,23-,26+,30+/m0/s1 JLAUWTQRXSHDPG-MCFYFMLRSA-N 374776 US10246467, Example I-76::US10919913, # I-76 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 13.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374776&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376473 404343828 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744687 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5ccnc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C29H22Cl2FN5O4/c30-15-4-6-18-20(10-15)34-28(40)29(18)22(17-7-8-33-25(31)23(17)32)24-21(36(29)11-13-1-2-13)12-41-26-16-5-3-14(27(38)39)9-19(16)35-37(24)26/h3-10,13,21-22,24H,1-2,11-12H2,(H,34,40)(H,38,39)/t21-,22-,24+,29+/m0/s1 ZFIVKXJNJGCIFB-MIMQBZNGSA-N 374777 US10246467, Example I-78::US10919913, # I-80 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 7.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374777&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376474 404343829 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744688 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5ccnc(Br)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C29H22BrClFN5O4/c30-25-23(32)17(7-8-33-25)22-24-21(12-41-26-16-5-3-14(27(38)39)9-19(16)35-37(24)26)36(11-13-1-2-13)29(22)18-6-4-15(31)10-20(18)34-28(29)40/h3-10,13,21-22,24H,1-2,11-12H2,(H,34,40)(H,38,39)/t21-,22-,24+,29+/m0/s1 ZITWZAOLQUPNCF-MIMQBZNGSA-N 374778 US10246467, Example I-80 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 6.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374778&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376475 404343830 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744689 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cc(Cl)nc(Cl)c5)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C29H22Cl3N5O4/c30-16-4-6-18-20(10-16)33-28(40)29(18)24(15-8-22(31)34-23(32)9-15)25-21(36(29)11-13-1-2-13)12-41-26-17-5-3-14(27(38)39)7-19(17)35-37(25)26/h3-10,13,21,24-25H,1-2,11-12H2,(H,33,40)(H,38,39)/t21-,24-,25+,29+/m0/s1 FPVVWXQDZUQRAS-JDFFVWOXSA-N 374779 US10246467, Example I-82::US10919913, # I-82 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 8.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374779&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376476 404343831 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744690 OC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4nc(Cl)ccc54)n3nc2c1 InChI=1S/C29H22Cl2FN5O4/c30-18-3-1-2-16(23(18)32)22-24-20(12-41-26-15-7-6-14(27(38)39)10-19(15)35-37(24)26)36(11-13-4-5-13)29(22)17-8-9-21(31)33-25(17)34-28(29)40/h1-3,6-10,13,20,22,24H,4-5,11-12H2,(H,38,39)(H,33,34,40)/t20-,22-,24+,29+/m0/s1 ILAHEWONKXXSHQ-YMFUCMRSSA-N 374780 US10246467, Example I-84::US10919913, # I-84 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 33.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374780&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376477 404343832 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744691 OC(=O)c1ccc2c3OCC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C31H25Cl2FN4O4/c32-17-7-9-20-23(13-17)35-30(41)31(20)25(19-2-1-3-21(33)26(19)34)27-24(37(31)14-15-4-5-15)10-11-42-28-18-8-6-16(29(39)40)12-22(18)36-38(27)28/h1-3,6-9,12-13,15,24-25,27H,4-5,10-11,14H2,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 UYOOIBOJVXNQAH-NCRFVDKVSA-N 374781 US10246467, Example I-86::US10919913, # I-86 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 35.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374781&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376478 404343833 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744692 COc1cc2c3OCC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2cc1C(O)=O InChI=1S/C32H27Cl2FN4O5/c1-43-25-13-18-22(12-19(25)30(40)41)37-39-28-24(9-10-44-29(18)39)38(14-15-5-6-15)32(26(28)17-3-2-4-21(34)27(17)35)20-8-7-16(33)11-23(20)36-31(32)42/h2-4,7-8,11-13,15,24,26,28H,5-6,9-10,14H2,1H3,(H,36,42)(H,40,41)/t24-,26-,28+,32+/m0/s1 PEHPVEPXWZTJFP-RNALLYIPSA-N 374782 US10246467, Example I-87::US10919913, # I-87 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 37.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374782&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376479 404343834 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744693 OC(=O)c1ccc2nn3[C@@H]4[C@H](CCOc3c2c1)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c32-17-7-8-20-23(13-17)35-30(41)31(20)25(18-2-1-3-21(33)26(18)34)27-24(37(31)14-15-4-5-15)10-11-42-28-19-12-16(29(39)40)6-9-22(19)36-38(27)28/h1-3,6-9,12-13,15,24-25,27H,4-5,10-11,14H2,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 MTMCGLLGXUUUNF-NCRFVDKVSA-N 374783 US10246467, Example I-88::US10919913, # I-88 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 10.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374783&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376480 404343835 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744694 NC(=O)c1ccc2nn3[C@@H]4[C@H](COc3c2c1)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H24Cl2FN5O3/c31-16-7-8-19-22(11-16)35-29(40)30(19)24(17-2-1-3-20(32)25(17)33)26-23(37(30)12-14-4-5-14)13-41-28-18-10-15(27(34)39)6-9-21(18)36-38(26)28/h1-3,6-11,14,23-24,26H,4-5,12-13H2,(H2,34,39)(H,35,40)/t23-,24-,26+,30+/m0/s1 XEJPOKGIITWYMH-HLNVOFQHSA-N 374784 US10246467, Example I-90::US10919913, # I-90 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 26.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374784&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376483 404343836 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744695 CCN(CC)C(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C34H32Cl2FN5O3/c1-3-40(4-2)31(43)19-10-12-21-25(14-19)39-42-30-27(17-45-32(21)42)41(16-18-8-9-18)34(28(30)22-6-5-7-24(36)29(22)37)23-13-11-20(35)15-26(23)38-33(34)44/h5-7,10-15,18,27-28,30H,3-4,8-9,16-17H2,1-2H3,(H,38,44)/t27-,28-,30+,34+/m0/s1 JGGRXRMUYIDZDJ-ZULBXXEESA-N 374785 US10246467, Example I-91::US10919913, # I-91 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 95.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374785&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376484 404343837 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744696 NC(=O)c1ccc2c3OC[C@H]4[C@H]([C@H](c5ccnc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2c1 InChI=1S/C29H23Cl2FN6O3/c30-15-4-6-18-20(10-15)35-28(40)29(18)22(17-7-8-34-25(31)23(17)32)24-21(37(29)11-13-1-2-13)12-41-27-16-5-3-14(26(33)39)9-19(16)36-38(24)27/h3-10,13,21-22,24H,1-2,11-12H2,(H2,33,39)(H,35,40)/t21-,22-,24+,29+/m0/s1 PJCZBMZDQXPJSN-MIMQBZNGSA-N 374786 US10246467, Example I-92::US10919913, # I-92 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 13.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374786&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376485 404343838 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744697 OC(=O)c1cc2c3OC[C@H]4[C@H]([C@H](c5cccc(Cl)c5F)[C@@]5(N4CC4CC4)C(=O)Nc4cc(Cl)ccc54)n3nc2cc1F InChI=1S/C30H22Cl2F2N4O4/c31-14-6-7-18-22(8-14)35-29(41)30(18)24(15-2-1-3-19(32)25(15)34)26-23(37(30)11-13-4-5-13)12-42-27-17-9-16(28(39)40)20(33)10-21(17)36-38(26)27/h1-3,6-10,13,23-24,26H,4-5,11-12H2,(H,35,41)(H,39,40)/t23-,24-,26+,30+/m0/s1 LGRCOTJIEFWWTP-HLNVOFQHSA-N 374787 US10246467, Example I-105::US10919913, # I-105 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 13.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374787&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376492 404343839 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744698 OC(=O)c1cc2nn3[C@@H]4[C@H](COc3c2cc1F)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C30H22Cl2F2N4O4/c31-14-6-7-18-22(8-14)35-29(41)30(18)24(15-2-1-3-19(32)25(15)34)26-23(37(30)11-13-4-5-13)12-42-27-17-9-20(33)16(28(39)40)10-21(17)36-38(26)27/h1-3,6-10,13,23-24,26H,4-5,11-12H2,(H,35,41)(H,39,40)/t23-,24-,26+,30+/m0/s1 WSHHPNWMQUMLND-HLNVOFQHSA-N 374788 US10246467, Example I-107::US10919913, # I-107 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 18.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374788&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376493 404343840 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744699 Cc1c(ccc2nn3[C@@H]4[C@H](COc3c12)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12)C(O)=O InChI=1S/C31H25Cl2FN4O4/c1-14-17(29(39)40)8-10-21-24(14)28-38(36-21)27-23(13-42-28)37(12-15-5-6-15)31(25(27)18-3-2-4-20(33)26(18)34)19-9-7-16(32)11-22(19)35-30(31)41/h2-4,7-11,15,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m0/s1 BEGADGRKUSCXTH-RXRCSWILSA-N 374789 US10246467, Example I-109::US10246467, Example I-110::US10919913, # I-110 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 11.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374789&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376494 404343841 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744700 Cc1c(ccc2nn3[C@@H]4[C@H](COc3c12)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12)C(O)=O InChI=1S/C31H25Cl2FN4O4/c1-14-17(29(39)40)8-10-21-24(14)28-38(36-21)27-23(13-42-28)37(12-15-5-6-15)31(25(27)18-3-2-4-20(33)26(18)34)19-9-7-16(32)11-22(19)35-30(31)41/h2-4,7-11,15,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m0/s1 BEGADGRKUSCXTH-RXRCSWILSA-N 374789 US10246467, Example I-109::US10246467, Example I-110::US10919913, # I-110 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 7.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374789&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376494 404343841 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744701 Cc1c(ccc2nn3[C@H]4[C@@H](COc3c12)N(CC1CC1)[C@@]1([C@@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12)C(O)=O InChI=1S/C31H25Cl2FN4O4/c1-14-17(29(39)40)8-10-21-24(14)28-38(36-21)27-23(13-42-28)37(12-15-5-6-15)31(25(27)18-3-2-4-20(33)26(18)34)19-9-7-16(32)11-22(19)35-30(31)41/h2-4,7-11,15,23,25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t23-,25-,27+,31+/m1/s1 BEGADGRKUSCXTH-OVRLWXHPSA-N 374791 US10246467, Example I-111::US10919913, # I-111 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 617 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374791&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376495 404343842 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744702 Cc1cc2nn3[C@@H]4[C@H](COc3c2cc1C(O)=O)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C31H25Cl2FN4O4/c1-14-9-22-19(11-18(14)29(39)40)28-38(36-22)27-24(13-42-28)37(12-15-5-6-15)31(25(27)17-3-2-4-21(33)26(17)34)20-8-7-16(32)10-23(20)35-30(31)41/h2-4,7-11,15,24-25,27H,5-6,12-13H2,1H3,(H,35,41)(H,39,40)/t24-,25-,27+,31+/m0/s1 MEPNXWGZCBHNAI-NCRFVDKVSA-N 374792 US10246467, Example I-112::US10919913, # I-112 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 15.0 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374792&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376496 404343843 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744703 OC(=O)c1cnc2nn3[C@@H]4[C@H](COc3c2c1)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C29H22Cl2FN5O4/c30-15-6-7-18-20(9-15)34-28(40)29(18)22(16-2-1-3-19(31)23(16)32)24-21(36(29)11-13-4-5-13)12-41-26-17-8-14(27(38)39)10-33-25(17)35-37(24)26/h1-3,6-10,13,21-22,24H,4-5,11-12H2,(H,34,40)(H,38,39)/t21-,22-,24+,29+/m0/s1 LKMZFXUNRYEKGW-MIMQBZNGSA-N 374793 US10246467, Example I-114::US10246467, Example I-115::US10919913, # I-115 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 9.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374793&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376497 404343844 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744704 OC(=O)c1cnc2nn3[C@@H]4[C@H](COc3c2c1)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C29H22Cl2FN5O4/c30-15-6-7-18-20(9-15)34-28(40)29(18)22(16-2-1-3-19(31)23(16)32)24-21(36(29)11-13-4-5-13)12-41-26-17-8-14(27(38)39)10-33-25(17)35-37(24)26/h1-3,6-10,13,21-22,24H,4-5,11-12H2,(H,34,40)(H,38,39)/t21-,22-,24+,29+/m0/s1 LKMZFXUNRYEKGW-MIMQBZNGSA-N 374793 US10246467, Example I-114::US10246467, Example I-115::US10919913, # I-115 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 4.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374793&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376497 404343844 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744705 OC(=O)c1cnc2nn3[C@H]4[C@@H](COc3c2c1)N(CC1CC1)[C@@]1([C@@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C29H22Cl2FN5O4/c30-15-6-7-18-20(9-15)34-28(40)29(18)22(16-2-1-3-19(31)23(16)32)24-21(36(29)11-13-4-5-13)12-41-26-17-8-14(27(38)39)10-33-25(17)35-37(24)26/h1-3,6-10,13,21-22,24H,4-5,11-12H2,(H,34,40)(H,38,39)/t21-,22-,24+,29+/m1/s1 LKMZFXUNRYEKGW-DWDWSSDJSA-N 374795 US10246467, Example I-116::US10919913, # I-116 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 144 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374795&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376499 404343845 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 744706 Cc1cc2nn3[C@@H]4[C@H](CCOc3c2cc1C(O)=O)N(CC1CC1)[C@]1([C@H]4c2cccc(Cl)c2F)C(=O)Nc2cc(Cl)ccc12 InChI=1S/C32H27Cl2FN4O4/c1-15-11-23-20(13-19(15)30(40)41)29-39(37-23)28-25(9-10-43-29)38(14-16-5-6-16)32(26(28)18-3-2-4-22(34)27(18)35)21-8-7-17(33)12-24(21)36-31(32)42/h2-4,7-8,11-13,16,25-26,28H,5-6,9-10,14H2,1H3,(H,36,42)(H,40,41)/t25-,26-,28+,32+/m0/s1 CFSDXIRRNDSJFD-CKHSQSCFSA-N 374796 US10246467, Example I-117::US10919913, # I-117 Cellular tumor antigen p53 [16-27]/E3 ubiquitin-protein ligase Mdm2 [23-117] Human 6.00 US Patent 10.7270/Q2VX0JT2 aid1798253 US10246467 Ramharter, J; Broeker, J; Gille, A; Gollner, A; Henry, M; Kerres, N; Weinstabl, H 4/2/2019 1/21/2020 Boehringer Ingelheim International GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=374796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=213&target=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=374796&enzyme=Cellular+tumor+antigen+p53+%5B16-27%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B23-117%5D&column=ki&startPg=0&Increment=50&submit=Search 130376498 404343846 2 EQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSD 1T4E,1T4F,1YCR,1Z1M,2AXI,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBK,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4DIJ,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4OQ3,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYC,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6HFA,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 QETFSDLWKLLP Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61